/
/
/
/
/
SALIX® (furosemide tablets)
Canine & Feline Other Pharmaceuticals
Product Description
SALIX® (furosemide tablets) are for the treatment of edema (swelling) associated with cardiac insufficiency (heart failure) and acute non-inflammatory tissue edema in dogs. SALIX is a proven diuretic (helps remove excess fluid) and saluretic (removes excess sodium from the kidneys) for prompt relief of edema (swelling).
| Product Name | Pkg Size | GTIN#/UPC# | UIN# |
|---|---|---|---|
| SALIX® Tablets (12.5 mg furosemide) (12 btls/case) | 1 x 500 tabs | 662858751345 | 066999 |
| SALIX® Tablets (50 mg furosemide) (6 btls/case) | 1 x 500 tabs | 662858430653 | 069005 |
Images
Important Safety Information
SALIX® (furosemide tablets): SALIX is a highly effective diuretic and if given in excessive amounts as with any diuretic may lead to excessive diuresis which could result in electrolyte imbalance, dehydration and reduction of plasma volume enhancing the risk of circulatory collapse, thrombosis, and embolism. Therefore, the animal should be observed for early signs of fluid depletion with electrolyte imbalance, and corrective measures administered. Excessive loss of potassium in patients receiving digitalis or its glycosides may precipitate digitalis toxicity. Caution should be exercised in animals administered potassium-depleting steroids. It is important to correct potassium deficiency with dietary supplementation. Caution should be exercised in prescribing enteric-coated potassium tablets. Consult your veterinarian and see package insert for full information regarding contraindications, warnings, and precautions. For additional information, please see the product label.
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global